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Metabolic syndrome (MS) is a complex disorder deﬁned by a cluster of abdominal obesity, atherogenic dyslipidemia, hyper-
glycemia, and hypertension; the condition is recognized as a risk factor for diabetes and cardiovascular disease. This study assessed
the eﬀects of the Sasang constitution group (SCG) on the risk of MS in Korean subjects. We have analyzed 1,617 outpatients of
Korean oriental medicine hospitals who were classiﬁed into three SCGs, So-Yang, So-Eum, and Tae-Eum. Signiﬁcant diﬀerences
were noted in the prevalence of MS and the frequencies of all MS risk factors among the three SCGs. The odds ratios for MS
as determined via multiple logistic regression analysis were 2.004 for So-Yang and 4.521 for Tae-Eum compared with So-Eum.
These results indicate that SCG may function as a signiﬁcant risk factor of MS; comprehensive knowledge of Sasang constitutional
medicine may prove helpful in predicting susceptibility and developing preventive care techniques for MS.
1.Introduction
Metabolic syndrome (MS) represents a cluster of metabolic
risk factors which can be deﬁned when three or more meta-
bolic disorders are present, namely, high blood glucose, low
high-density lipoprotein cholesterol (HDL-C), high blood
pressure, high serum triglyceride (TG) levels, and abdominal
obesity [1–4]. According to the Third National Health and
Nutrition Examination Survey, the age-adjusted prevalence
of MS as deﬁned by the US National Cholesterol Education
Program Adult Treatment Panel III (NCEP ATP III) is 23.7%
in the general population but varies from 16 percent in black
men to 37 percent in Hispanic women [5].
MS is signiﬁcantly associated with increased risk of
developing diabetes and cardiovascular disease (CVD). In
particular, CVD is characteristically sudden in onset and life
threatening; therefore it is necessary to develop a suitable
preventive care method. Not only individuals with diabetes
and CVD, but also individuals with MS are seemingly
susceptible to other conditions, most notably polycystic
ovary syndrome, fatty liver, cholesterol gallstones, asthma,
sleep disturbances, and some forms of cancer [6]. It has been
noteddistinctpatternsofcardiometabolicriskfactorsamong
diﬀerent ethnic groups in the National Health and Nutrition
Examination Survey (NHANES) sample [7, 8].
Sasang constitutional medicine (SCM) is a type of a
Korean traditional medicine that classiﬁes human beings
into four constitutions, Tae-Yang (TY), So-Yang (SY), Tae-
Eum (TE), and So-Eum (SE), based on their traits [9–11].
Each constitution shares common aspects of bodily struc-
ture, function, and metabolism, as well as psychological and
behavioralcharacteristics[10].Additionally,ithasbeenindi-
cated that each constitution has diﬀerent susceptibility to
pathology and the prevalence and relative risk of several
chronic diseases were found to diﬀer across diﬀerent Sasang
constitution groups (SCGs) [10, 12].
In SCM, the same disease is frequently treated dif-
ferently for diﬀerent individuals based on constitutionally
diﬀerentiated traits in clinical practice [13]. Since MS is a
signiﬁcant precursor of diabetes and CVD, the constitutional
diﬀerences in characteristics and prevalence of MS may facil-
itate improved patient care and prognoses. In this study, we2 Evidence-Based Complementary and Alternative Medicine
Table 1: General characteristics of the study subjects.
Variables
Mean ± SD
P value Male (n = 593) Female (n = 1024) Total (n = 1617)
Age (years) 47.26 ±14.91 48.45 ±14.95 48.12 ± 14.9 0.078
FBG (mg/dL) 102.17 ±30.48 96.45 ±25.23 98.56 ±27.53 5.81E −05
HDL-C (mg/dL) 41.7 ±10.20 48.66 ±11.98 46.11 ±11.83 2.52E − 31
SBP (mmHG) 122.99 ±13.88 119.08 ±14.94 120.52 ± 14.67 2.25E − 07
DBP (mmHG) 79.68 ±10.55 76.28 ±11.17 77.53 ±11.07 2.37E − 09
TG (mg/dL) 150.52 ±97.26 117.48 ±72.61 129.7 ±83.84 1.79E − 14
WC (cm) 86.96 ±8.86 82.7 ± 10.09 84.27 ± 9.87 4.01E − 17
Values are indicated as the mean±standard deviation.
P value: Student’s T-test result between male and female.
FBG: fasting blood glucose; HDL-C: high-density lipoprotein cholesterol; SBP: systolic blood pressure; DBP: diastolic blood pressure; TG: triglyceride; WC:
waist circumference.
assess the prevalence of MS and evaluate its risk factors in a
large population-based study with Korean subjects classiﬁed
by SCM.
2.MaterialsandMethods
2.1. Study Population. All samples and clinical information
including his/her Sasang constitution type were deposited
in the databank of Sasang constitutional medicine (DB-
SCM) in Korea Institute of Oriental Medicine as previously
described in detail [14]. However, 2 of the previous 1,619
participants were excluded due to the omission of their
waist circumstance or blood pressure results. Therefore,
the current study population included a total of 1,617
participants (593 males and 1,024 females).
2.2. Criteria for MS. MS was deﬁned according to NECP
ATP III guidelines, which stipulated that at least 3 out of
5 of the following criteria had to be met: (1) fasting blood
glucose (FBG) ≥ 100mg/dL or taking antihyperglycemic
medication, (2) TG ≥ 150mg/dL, (3) HDL-C ≤ 40mg/d for
male and 50mg/dL for female, (4) systolic blood pressure
(SBP) ≥ 130mmHg and/or diastolic blood pressure (DBP)
≥ 85mmHg or taking antihypertensive medication, and
(5) central obesity with waist (WC) ≥ 90cm for men and
≥80cm for women. For FBG levels, we referred to American
Diabetes Association (ADA) guidelines [15]a n du s e da
modiﬁed WC cutoﬀ of ≥90cm in men and ≥80cm in
women for abdominal obesity cutoﬀ ranges [16].
2.3. Statistics. The quantitative variables were expressed as
mean ± standard deviation. Student’s T-test was used to
analyze the diﬀerence between genders. Analysis of variance
(ANOVA) was employed to analyze the diﬀerences among
theSCGs.χ2 testswereconductedtoevaluatethesigniﬁcance
of subgroup diﬀerences.
Multiple logistic regression analyses were conducted to
calculate the odds ratio as a measure of relative risk of MS
between SE and SY and between SE and TE. Odds ratios
(ORs)wereestimatedwiththeir95%CI,andthesigniﬁcance
threshold was set as P<0.05. All statistical analyses were
performed using SPSS (SPSS Inc., Chicago, IL; V14.0 for
Windows).
3. Results
3.1. Characteristics and Prevalence of MS in the Total Study
Population. A total of 1,617 individuals, 593 males and
1,024 females, were enrolled in this study. The general
characteristicsofstudysubjects,includingage,FBG,HDL-C,
SBP,DBP,TG,andWC,forthisstudyasatotalandaccording
to gender were shown in Table 1.
The prevalence of MS and the relative frequencies of
the individual risk factor of the MS in men and women
are summarized in Table 2. Using the modiﬁed NECP ATP
III diagnostic criteria, we detected a 35.37% prevalence of
MS in the study population. Low HDL-C was the most
common risk factor of MS according to the modiﬁed NECP
ATP III criteria in both males and females. Males had a
higher prevalence of hyperglycemia (P = 3.207E − 06),
hypertension (P = 4.234E − 06), and hypertriglyceridemia
(P = 2.911E − 09) than females. The frequency of large
WC (P = 7.289E − 17) was higher in females than males.
The frequency order of the risk factors of MS was low HDL-
C > large WC > high BP > high FBG > high TG in total
population, low HDL-C > high BP > high TG > large WC
> high FBG in males, and large WC > low HDL-C > high BP
> high FBG > high TG in females.
3.2. Prevalence of MS according to SCGs. To further address
the prevalence of MS by SCM, 1,617 individuals were
classiﬁed into three constitution groups and by gender, as
described in Section 2. The clinical characteristics of the
three SCGs separated by gender were described in Table 3.
We detected statistically signiﬁcant interconstitutional varia-
tions in all parameters.
The TE group evidenced signiﬁcantly elevated FBG, SBP,
DBP, TG, and WC and depressed HDL-C as compared to
the SY and SE groups. The prevalence of MS was 18.02%,
30.59%, and 48.85% in total SE, SY, and TE, respectively
(Table 4, P = 5.07E−24). Both males and females evidenced
signiﬁcant diﬀerences in the prevalence of MS according to
SCGs. Moreover, signiﬁcant diﬀerences were noted in theEvidence-Based Complementary and Alternative Medicine 3
Table 2: The prevalence of MS and risk factors of the study subjects.
Variables
Number (%)
P value Male Female Total
MS 212 (35.75) 360 (35.16) 572 (35.37) 0.810
High FBG 220 (37.1) 267 (26.07) 487 (30.12) 3.207E −06
Low HDL-C 283 (47.72) 596 (58.2) 879 (54.36) 4.559E −05
High BP 242 (40.81) 303 (29.59) 545 (33.70) 4.234E −06
High TG 223 (37.61) 243 (23.73) 466 (28.82) 2.911E −09
Large WC 221 (37.27) 602 (58.79) 823 (50.9) 7.289E −17
Values are indicated as number (%).
P value: Chi-square test between male and female.
MS: metabolic syndrome; FBG: fasting blood glucose; HDL-C: high-density lipoprotein cholesterol; TG: triglyceride; WC: waist circumference.
frequencies of all MS risk factors among the three SCGs
according to Chi-Square test results.
Low HDL-C was the top MS risk factor for MS using the
modiﬁed NECP ATP III criteria in both SE and SY, but large
WC was the top MS risk factor in TE. The frequency order
of the risk factors of MS was as follows: low HDL-C > large
WC > high BP > high FBG > high TG in SE and SY and large
WC > low HDL-C > high BP > high TG > high FBG in TE.
Interestingly, the frequencies of the individual risk factors of
MS varied according to SCGs in both males and females. In
males, the frequency order of the risk factors of MS was as
follows:low HDL-C> high BP> high FBG > high TG> large
WC in SE and SY and low HDL-C > large WC > high TG >
high BP> high FBG in TE. In females, the frequency order of
the risk factors of MS was as follows: low HDL-C > large WC
> high BP > high FBG > high TG in SE, low HDL-C > large
WC > high FBG > high BP > high TG in SY, and large WC >
low HDL-C > high BP> high TG > high FBG in TE. High BP
and high HDL-C were signiﬁcantly more prevalent in the SE
and SY than TE in males and females, respectively, but large
WC was signiﬁcantly more prevalent in the TE than SE and
SY in both males and females.
T h ep r e v a l e n c eo fM Sb y2 0 - y e a ra g eg r o u p si sp r e s e n t e d
in Figure 1. The prevalence of MS increased with age in both
males and females, with sharp increases at 30S in males
and at 50S in females, respectively. Moreover, signiﬁcance
diﬀerences in the prevalence of MS were noted in each age
category among the three SCGs via the Chi-Square test (P =
0.01, 8.412E − 11, 3.460E − 23, 2.974E − 05, resp.). The TE
group evidenced the highest prevalence of MS, followed by
SY and SE. However, there were no statistical signiﬁcant in
the prevalence of MS only in the 70–89 age category of males
and in the 10–29 age category of females among three SCGs
by the Chi-Square test.
3.3. ORs of MS according to SCGs. Since our ﬁndings indi-
cated that SCG was a factor that was signiﬁcantly associated
with the prevalence of MS, we calculated ORs for MS using
multiple logistic regression analysis to compare the preva-
lence of MS according to SCGs (Table 5). Using a logistic
regression model with SE as a reference due to its lowest level
of prevalence in MS, we determined that the ORs for occur-
rence of the MS were 2.004 for SY (95% CI, 1.467–2.738,
P = 1.26E − 05) and 4.521 for the TE (95% CI, 3.364–6.074,
P = 1.38E − 23). Additionally, signiﬁcantly higher ORs
were presented in males compared with females accord-
ing to SCGs.
4. Discussion
The prevalence of MS has increased in recent years, par-
ticularly among older adults in Korea; this may constitute
a public health problem [17]. The current study provided
strong statistical support for the prevalence of MS and
distinct risk proﬁles according to SCGs in Korea.
AlthoughtheprevalenceofMSaccordingtothemodiﬁed
NCEP ATP III criteria in the current study did not show
gender-speciﬁc diﬀerences, the order of MS risk factors
diﬀered signiﬁcantly according to gender. Consistent with
the results of several population studies, we also reported an
increaseintheprevalenceofMSwithagesuggestingthatage-
related changes in body size, fat distribution, and increases
in insulin resistance contribute to the increased prevalence
of MS with age [5, 17, 18]. Our data demonstrated that
the males tend to have a higher prevalence of MS than the
females in the 30–49 age group. However, the females have
a higher prevalence than the males in the 50–69 age group,
suggesting that menopause is one factor contributing to this
change in MS prevalence [19, 20].
ItshouldbenotedthatweobservedtheimpactofSCGon
the diﬀerences in the prevalence of MS and risk factor of MS.
These ﬁndings are reminiscent of the theory of SCM, which
holds that there are diﬀerences in susceptibility to patho-
logical conditions according to SCG [10, 12]. It has been
reported that the TE group tends to gain weight and that
cardiovascular and metabolic disorders, such as hyperten-
sion,diabetesmellitus,andhyperlipidemia,appearwithhigh
prevalence in the TE group implying that TE is more predis-
posed to suﬀer from MS [10]. More interestingly, abdominal
obesity predominated as a risk factor of MS in TE, but hypo-
HDL-C predominated as a risk factor for MS in SE and SY.
Recently, we have reported that apolipoprotein A5-1131
genetic polymorphism is associated with lower serum HDL-
C and higher TG in SY and TE, but not in SE subjects [14].
Interestingly, low HDL-C and high TG were more prevalent
in SY and TE than in SE suggesting that the association of4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: The prevalence of the MS according to SCG. The prevalence of MS according to SCG in total study population (a), male study
population (b), and female study population (c) are shown, respectively.
this polymorphism with MS is attributable to its eﬀects on
HDL-C and TG metabolism. However, the genetic basis of
MS according to SCG remains to be deﬁnitively elucidated.
In our study, SCG was associated signiﬁcantly with
increased odds of MS in our multiple logistic regression
analysis. In agreement with previous reports that the
prevalence of diabetes and insulin resistance were higher in
T Et h a ni nS Ea n dS Y[ 12, 21], we found that the prevalence
of MS was higher in TE than in SE and SY. Furthermore, the
ORs of MS were also higher with age in TE (See Supplemen-
tary Table S1 available online at doi: 10.1155/2012/646794).
The diﬀerences in the prevalence of MS according to
SCG suggest that SCG may function as a signiﬁcant risk
factor of MS susceptibility [10]. The present study not only
discloses the exceptionally higher prevalence of MS in TE
than in SE and SY, but also suggests the beginnings of a
comprehensive understanding of SCG for preventive SCG-
speciﬁc care. Additionally, the number of participants withEvidence-Based Complementary and Alternative Medicine 7
Table 5: Odds ratio of MS according to SCG.
Variables Gender Constitution (Number) OR
95% CI
P-value Lower Upper
MS
Total
SE (405) 1 — — —
SY (546) 2.004 1.467 2.738 1.26E –05
TE (666) 4.521 3.364 6.074 1.38E –23
Male
SE (141) 1 — — —
SY (186) 3.211 1.813 5.686 6.33E − 05
TE (266) 6.231 3.631 10.691 3.09E − 11
Female
SE (264) 1 — — —
SY (360) 1.601 1.1 2.331 0.014
TE (400) 3.928 2.747 5.616 6.41E − 14
Abbreviations: MS, metabolic syndrome; SY, So-Yang; SE, So-Eum; TE, Tae-Eum; OR, odds ratio; CI, conﬁdence interval.
P-value: multiple logistic regression analysis according to SCG.
Numbers of participants are indicated in a round bracket.
o n eo rm o r eM Sr i s kf a c t o r ss u g g e s t st h eT Eg r o u pi sp o t e n -
tially at risk for developing MS (See Supplementary Table
S2). Therefore,we believe that the comprehensive knowledge
of SCG may prove helpful in predicting MS susceptibility;
our ﬁndings should attract increased attention to the typo-
logical aspects of classifying a very high portion of the
asymptomatic population such as TE, as being in need of
counseling,andoverallriskassessmentformetabolicdiseases
such as CVD.
5. Conclusions
In conclusion, the results of this study demonstrated that the
prevalence of MS and the frequencies of all MS risk factors
among the three SCGs; the TE group evidenced the highest
prevalence of MS followed by the SY and SE groups. These
results indicate that SCG may function as a signiﬁcant risk
factor for MS, and comprehensive knowledge of SCM may
prove helpful in predicting susceptibility to and adequate
methods for the preventive care of MS.
Abbreviations
MS: Metabolic syndrome
SCM: Sasang constitutional medicine
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